Kangwon Land (035250)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 14,160.00 |
|---|---|
| 52-week range | 13,920.00 – 19,590.00 |
| Return, 1 month / 3 months | −1.1% / −1.7% |
| Return, 1 year / 3 years | −12.5% / +15.5% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 21.2% |
| Worst drawdown (1 year) | -23.7% |
| Average daily value traded | 4,253.23M KRW |
| Dividend yield | 6.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kangwon Land runs a casino and resort complex in the mountain town of Sabuk in Gangwon province, Korea. The casino admits local Korean patrons, which sets it apart from the country's other casinos that serve foreign visitors only. Alongside gaming, the company operates hotels, a golf course and ski facilities, drawing leisure travellers and tour groups to the region. It also supports the surrounding community, which grew from a former mining area.
Kangwon Land trades under the code 035250 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kangwon Land (035250) trades on the Korea Stock Exchange in Korea. It last closed at KRW 14,160.00 on 23 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 140 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.5% and over the last three months it fell 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -10.2% | ||
| From 52-week high | -27.5% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.7% | ||
| 6-month return | -15.7% | ||
| 12-month return, skipping the last month | -11.5% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.7% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 4,253.23M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.7% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −1.1% |
| 3 months | −1.7% |
| 6 months | −15.7% |
| 1 year | −12.5% |
| 3 years | +15.5% |
| 5 years | −39.7% |
Signals
| 50-day / 200-day average | 14,474.80 / 15,773.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 239.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 Mar 2026 | KRW 950.0000 |
| 3 Apr 2025 | KRW 1,170.0000 |
| 27 Dec 2023 | KRW 930.0000 |
| 28 Dec 2022 | KRW 350.0000 |
| 29 Dec 2020 | KRW 900.0000 |
| 27 Dec 2019 | KRW 900.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.